FAM107A and prostate cancer: The CCK-8 assay showed that the cell proliferation ability of the pc-FAM107A group was significantly decreased compared to that of the pc-Vector group starting from the third day, indicating that the overexpression of FAM107A inhibited the proliferation and growth of prostate cancer cells (p < 0.01) (Figure 4B).